Post-traumatic headache (PTH) shares many of the same symptoms as migraines. Characterized by severe pain and sensory hypersensitivity, they’re disruptive and often difficult to treat. Despite the similarities, there are currently no FDA-approved treatments specifically for PTH. This gap in care is what drives University of Iowa Health Care researcher Levi Sowers, assistant professor in the Stead Family Department of Pediatrics and the Division of Child Neurology.